Aviva’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $31.7M | Buy |
97,065
+7,012
| +8% | +$2.29M | 0.07% | 279 |
|
|
2025
Q1 | $24.3M | Buy |
90,053
+12,809
| +17% | +$3.46M | 0.06% | 307 |
|
|
2024
Q4 | $18.2M | Buy |
77,244
+52,738
| +215% | +$12.4M | 0.05% | 341 |
|
|
2024
Q3 | $6.74M | Buy |
24,506
+13,615
| +125% | +$3.74M | 0.02% | 453 |
|
|
2024
Q2 | $2.65M | Buy |
10,891
+6,113
| +128% | +$1.49M | 0.01% | 561 |
|
|
2024
Q1 | $714K | Sell |
4,778
-3,149
| -40% | -$471K | ﹤0.01% | 711 |
|
|
2023
Q4 | $1.52M | Sell |
7,927
-20,481
| -72% | -$3.92M | 0.01% | 628 |
|
|
2023
Q3 | $5.03M | Buy |
28,408
+20,451
| +257% | +$3.62M | 0.02% | 503 |
|
|
2023
Q2 | $1.51M | Sell |
7,957
-99,215
| -93% | -$18.8M | 0.01% | 706 |
|
|
2023
Q1 | $21.5M | Sell |
107,172
-22,668
| -17% | -$4.54M | 0.1% | 314 |
|
|
2022
Q4 | $30.9M | Buy |
129,840
+42,365
| +48% | +$10.1M | 0.15% | 164 |
|
|
2022
Q3 | $17.5M | Buy |
87,475
+4,610
| +6% | +$923K | 0.1% | 283 |
|
|
2022
Q2 | $12.1M | Buy |
82,865
+9,825
| +13% | +$1.43M | 0.06% | 405 |
|
|
2022
Q1 | $11.9M | Buy |
73,040
+34,823
| +91% | +$5.69M | 0.06% | 387 |
|
|
2021
Q4 | $6.48M | Buy |
38,217
+1,965
| +5% | +$333K | 0.03% | 520 |
|
|
2021
Q3 | $6.85M | Sell |
36,252
-3,571
| -9% | -$674K | 0.03% | 487 |
|
|
2021
Q2 | $6.75M | Buy |
39,823
+1,396
| +4% | +$237K | 0.03% | 502 |
|
|
2021
Q1 | $5.43M | Sell |
38,427
-9,613
| -20% | -$1.36M | 0.03% | 514 |
|
|
2020
Q4 | $6.24M | Sell |
48,040
-6,125
| -11% | -$796K | 0.03% | 444 |
|
|
2020
Q3 | $7.89M | Buy |
54,165
+799
| +1% | +$116K | 0.05% | 342 |
|
|
2020
Q2 | $7.9M | Sell |
53,366
-5,730
| -10% | -$849K | 0.05% | 330 |
|
|
2020
Q1 | $6.43M | Buy |
59,096
+33,759
| +133% | +$3.67M | 0.05% | 348 |
|
|
2019
Q4 | $2.92M | Sell |
25,337
-1,618
| -6% | -$186K | 0.02% | 589 |
|
|
2019
Q3 | $2.17M | Sell |
26,955
-11,578
| -30% | -$931K | 0.01% | 623 |
|
|
2019
Q2 | $2.8M | Buy |
38,533
+3,882
| +11% | +$282K | 0.02% | 597 |
|
|
2019
Q1 | $3.24M | Buy |
34,651
+1,249
| +4% | +$117K | 0.02% | 569 |
|
|
2018
Q4 | $2.44M | Sell |
33,402
-9,044
| -21% | -$659K | 0.02% | 599 |
|
|
2018
Q3 | $3.72M | Sell |
42,446
-1,380
| -3% | -$121K | 0.02% | 603 |
|
|
2018
Q2 | $4.32M | Sell |
43,826
-29
| -0.1% | -$2.86K | 0.03% | 566 |
|
|
2018
Q1 | $5.22M | Buy |
+43,855
| New | +$5.22M | 0.03% | 504 |
|
|
2017
Q1 | – | Sell |
-48,022
| Closed | -$1.8M | – | 760 |
|
|
2016
Q4 | $1.8M | Buy |
48,022
+2,793
| +6% | +$105K | 0.01% | 697 |
|
|
2016
Q3 | $3.07M | Buy |
45,229
+1,103
| +2% | +$74.8K | 0.02% | 656 |
|
|
2016
Q2 | $2.45M | Buy |
44,126
+7,499
| +20% | +$416K | 0.02% | 666 |
|
|
2016
Q1 | $2.3M | Buy |
36,627
+207
| +0.6% | +$13K | 0.02% | 670 |
|
|
2015
Q4 | $3.43M | Sell |
36,420
-110
| -0.3% | -$10.4K | 0.03% | 599 |
|
|
2015
Q3 | $2.94M | Buy |
+36,530
| New | +$2.94M | 0.02% | 630 |
|